FEATURED

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

  • All
  • Education
  • Events
  • Press Releases
See more news
See more press releases

Social media

Join us in congratulating Andrew Barnett on his promotion to Senior Director of Market Access!

With 22+ years of experience, Andrew’s leadership and collaboration continue to strengthen patient access and drive growth.

#NSPharma #Leadership #MarketAccess #Promotion https://x.com/NSPharmaInc/status/2026673994007478491/photo/1

We’re excited to join the upcoming #CureDuchenne Workshop for a day of meaningful dialogue around #Duchenne care, research, and lived experiences. We value the chance to learn and support this inspiring community.

Learn more: https://ow.ly/cUeW50YiHEr

#NSPharma https://x.com/NSPharmaInc/status/2024861964501995630/photo/1

Please welcome Saori Yamaguchi to #NSPharma as Associate Director, Business Development.

With 10+ years of global experience across pharma and consulting, Saori brings strong expertise in strategy and launch planning. We’re excited to have her on the team!

#NewHire https://x.com/NSPharmaInc/status/2023412550486860231/photo/1

What an incredible experience at #WORLDSymposium 2026. We were grateful to welcome over 70 attendees to our #MPSII session.

Thank you to Drs. Hoffman, Burton and Jalazo for an outstanding discussion and to everyone who joined, asked questions, and helped make it so impactful. https://x.com/NSPharmaInc/status/2022325330032161027/photo/1

4

Today we celebrate #InternationalDayofWomenandGirlsinScience by recognizing the women at #NSPharma whose leadership and dedication drive progress.

Across research, development and patient focused roles, their expertise strengthens innovation and advances #RareDisease care. https://x.com/NSPharmaInc/status/2021600138397933684/video/1

We’re Hiring a #PatientEngagement Lead to support individuals and families living with #RareDiseases.

You could help patients navigate access, support, and care for conditions like #Duchenne and Hunter syndrome.

Learn more and apply: https://ow.ly/4wIE50Yby0l

#NSPharma https://x.com/NSPharmaInc/status/2020877306554634374/photo/1

We’re looking forward to attending #CureDuchenne Atlanta!

These sessions support meaningful dialogue and collaboration among patients, caregivers, healthcare professionals, and researchers.

Learn more here: https://ow.ly/QVMT50Y9Qz4

#NSPharma #RareDiseases #CommunityEngagement https://x.com/NSPharmaInc/status/2019788549822841016/photo/1